Results 61 to 70 of about 42,854,947 (301)

Text+Plus, #02: DLA Data+, oder: Marbach goes Text+

open access: yes, 2023
#02: DLA Data+ Jedes Jahr fördert Text+ Kooperationsprojekte mit einer Laufzeit von maximal 12 Monaten. Bewerben können sich Einzelpersonen, Arbeitsgruppen, Forschungsverbünde und Forschungseinrichtungen.
Karin Schmidgall
core   +1 more source

Text classification method review [PDF]

open access: yes, 2007
With the explosion of information fuelled by the growth of the World Wide Web it is no longer feasible for a human observer to understand all the data coming in or even classify it into categories.
Tiwari, Ashutosh   +3 more
core   +5 more sources

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Text+ loves Data

open access: yes
Auch wir lieben bekanntermaßen Daten. Daher ist Text+ natürlich auch bei der diesjährigen Love Data Week dabei, die vom 12. bis 16. Februar stattfindet.
Text+ Blog-Redaktion
core   +1 more source

Improving reference prioritisation with PICO recognition

open access: yesBMC Medical Informatics and Decision Making, 2019
Background Machine learning can assist with multiple tasks during systematic reviews to facilitate the rapid retrieval of relevant references during screening and to identify and extract information relevant to the study characteristics, which include ...
Austin J. Brockmeier   +3 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Text+ auf der OPERAS-Konferenz 2024

open access: yes
Autor:innen: Nanette Rißler-Pipka, Angela Vorndran, Philippe Genêt, Eva-Maria Gerstner Bei der kommenden OPERAS conference 2024, die vom 24. bis zum 26.
Text+ Mitglied
core   +1 more source

Towards saturation attack detection in SDN: a multi-edge representation learning-based method

open access: yesJournal of King Saud University: Computer and Information Sciences
Saturation attack detection in Software-Defined Networking (SDN) focuses on identifying and mitigating flow table overflow attacks on switches and overload attacks on the SDN controller.
Zhangli Ji   +5 more
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Defects and defect-mediated engineering of two-dimensional materials: challenges and open questions

open access: yesBeilstein Journal of Nanotechnology
Compared to bulk solids, defects in low-dimensional materials and, specifically, 2D systems are expected to have a stronger effect, detrimental or beneficial, on their properties.
Arkady V. Krasheninnikov   +30 more
doaj   +1 more source

Home - About - Disclaimer - Privacy